Service de Laboratoire de Parasitologie et Mycologie Médicale-PTM - CHU de Strasbourg - France
Strasbourg, 67091, France
NCT Number: NCT05527119
Malaria remains the world's leading parasitic endemic. Almost half of the world's population lives in endemic areas. Many at-risk people in African countries remain without access to malaria control. Malaria kills approximately 400,000 people each year, most of whom are children under the age of 5 in Africa. Since 2005, an increasing number of Plasmodium vivax infections have been observed in Duffy-negative populations in South America and Africa, calling into question the essential role of the PvDBP-DARC interaction. The objective of the investigators is therefore to study and understand the invasion pathways used by Plasmodium vivax in Duffy-negative subjects.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Strasbourg, 67091, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months later
University Hospital, Strasbourg, France
Other
Acronym: DARC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06575647
Infections, Malaria
Mae Sot, Changwat Tak, Thailand
View Trial DetailsNCT01157897
Infections, Malaria
Silver Spring, Maryland, United States
View Trial DetailsNCT01816113
Infections, Malaria
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT04411836
Infections, Malaria
Pursat, Cambodia
View Trial Details